NEW PROMO: Treatments > 50 million cells receive FREE 50 BILLION Exosomes IV!*
Chronic kidney disease (CKD) and kidney failure are common conditions, associated with 12% of cardiovascular and all-cause mortality. End stage renal disease (ESRD), or kidney failure, accounts for 6% of the Medicare spending in the United States. The major causes of kidney failure are hypertension and diabetes mellitus.
Current treatment options often fail due to the progression of renal disease. The pathology involves tubulointerstitial fibrosis, oxidative damage, glomerular fibrosis, and microvascular rarefaction. The kidneys have intrinsic regenerative capacity, which allows them to recover after minimal injury. The regenerative potential of these organs is limited, however.
Stem cell infusions are now being used to treat kidney failure with positive outcomes. Mesenchymal stem cells (MSCs) produce cytokines and growth factors that support hematopoiesis. These cells can transform into renal epithelial cells, functional mesangial cells, and tubular cells. Research shows that each stem cell viability is 95%, and injections work 99% of the time. MSCs have ability to reduce inflammatory response, reduce apoptosis, and increase renal function recovery.
Most chronic kidney disease patients are treated with stem cells and show improvement in the following areas:
Stem cells at R3 Stem Cell are harvested in a very safe process from consenting donors after a scheduled c-section. No babies or mother are harmed during the process. These cells possess unique immunomodulatory properties that relieve inflammation, and they can facilitate renal tissue repair. Several clinical studies have proved that stem cells are safe and effective for treating renal failure. Some research suggests that stem cells can change into ectodermal and endodermal lineages, and secrete growth factors, cytokines, and chemokines.
In a recent clinical study, researchers found that stem cells possessed a high potential for angiogenesis (vessel re-growth). In addition, investigators noted local tissue turnover and repair of kidney damage after stem cell therapy. The cells were also noted to go to the site of kidney injury. The stem cells are known to release dozens of active biological factors that act on local cell dynamics, reduce inflammation, lessen fibrosis, and recruit resident progenitor cells.
A phase 1 research study involved stem cell infusions given one week after kidney transplant surgery. The researchers found that they decreased graft rejection, and both patients had excellent kidney function at the 1-year follow-up evaluation. The patients also recovered faster from surgery, had less complications, and few adverse effects. Another similar study involving five people with renal failure involved administration of stem cell injections. Six months after transplant, a noted immunomodulatory effect was noted.
Another clinical study showed feasibility and safety of stem cell infusion for the treatment of renal disease. The study involved several cohort patients, as well as a control group. The stem cells were infused through the renal artery. At the 1-year follow-up, researchers noted a beneficial effect and reduced dosage requirement of immunosuppressive drugs. These clinical trials prove effectiveness and safety of stem cell therapy for renal diseases. Notable findings include improved resolution of tubular atrophy and interstitial fibrosis, as well as decreased risk of infection, positive effects of infusion, and lower incidence of acute rejection.
Peired AJ, Sisti A, & Romagnani P (2016). Mesenchymal Stem Cell-Based Therapy for Kidney Disease: A Review of Clinical Evidence. Stem Cells Int, 4798639.
Perico N, Casiraghi F, Introna M, Gotti E, Todeschini M, Cavinato RA, et al. Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility. Clin J Am Soc Nephrol. 2011;6:412–422
Reinders ME, de Fijter JW, Roelofs H, Bajema IM, de Vries DK, Schaapherder AF, et al. Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study. Stem Cells Transl Med.
Indications For Stem Cell Therapy At R3 Centers:
“The Clinic And Staff Are Very Professional. I Had A Great Time, From Their Pick Up In San Diego, To My Hotel In Tijuana. The Procedure At The Clinic Is Quite Simple. In A Few Hours, Everything Is Finished. The Doctor Explained The Injections To Me (Intravenous, In The Hip, And In The Back, At My Request) And Seems To Be Passionate About Stem Cells, It Was A Pleasure To Chat With Him 🙂
I Can Encourage You To Go To This Clinic.”
Julien B, Canada
The Response To Our Mexico Stem Cell Programs Have Been OVERWHELMING!
Make Sure To Reserve Your Spot Now By Calling Us At (888) 988-0515.
Our Experienced Providers Will Perform A Free Phone Consultation To See If You Are A Candidate.